The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients

被引：0
|
作者：
Anastasiou, M. [1 ]
Oikonomou, E. [2 ]
Theofilis, P. [3 ]
Papamikroulis, G. A. [2 ]
Gazouli, M. [4 ]
Pesiridis, T. [2 ]
Goliopoulou, A. [2 ]
Papatheodoridi, D. [5 ]
Psyrri, A. [1 ]
Zagouri, F. [5 ]
Siasos, G. [2 ]
Tousoulis, D. [3 ]
机构：
[1] Attikon Univ Hosp, Athens, Greece
[2] Sotiria Reg Chest Dis Hosp, Dept Cardiol 3, Athens, Greece
[3] Hippokrateion Hosp, Athens, Greece
[4] Univ Athens, Sch Med, Athens, Greece
[5] Alexandra Univ Hosp, Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Double-Edged Sword: Controversies in Anthracycline-Based Chemotherapy for Breast Cancer
    Kota K.J.
    Brufsky A.M.
    Current Breast Cancer Reports, 2017, 9 (4) : 210 - 216
  • [42] HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Yao, L.
    Liu, Y.
    Li, Z.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1326 - 1331
  • [43] Anthracycline-based Chemotherapy in A Patient with Breast Cancer and Left-Ventricular Hypertrabeculation
    Rahme, Serena Joseph
    Cathcart-Rake, Elizabeth
    Giudicessi, John
    Giudicessi, John
    Herrmann, Joerg
    CIRCULATION, 2024, 150
  • [44] ANTHRACYCLINE-BASED CHEMOTHERAPY FOR BREAST CANCER - PREDICTIVE FACTORS OF DOSE INTENSITY REDUCTION
    Faustino, C.
    Afonso, N.
    Sousa, B.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 82 - 82
  • [45] Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
    Yersal, Ozlem
    Eryilmaz, Ufuk
    Akdam, Hakan
    Meydan, Nezih
    Barutca, Sabri
    CARDIOLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [46] More than half of breast cancer patients develop diastolic dysfunction after anthracycline-based chemotherapy
    Serrano, Jose M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (08) : 443 - 443
  • [47] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Vargas-Roig, L. M.
    Cuello-Carrion, F. D.
    Fernandez-Escobar, N.
    Daguerre, P.
    Leuzzi, M.
    Ibarra, J.
    Gago, F. E.
    Nadin, S. B.
    Ciocca, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Menstrual disorders during anthracycline-based adjuvant chemotherapy in very young early breast cancer patients
    Neskovic-Konstantinovic, Z.
    Strbac, D.
    Susnjar, S.
    Vukotic, D.
    Gavrilovic, D.
    BREAST, 2007, 16 : S42 - S42
  • [49] Benefits of dexrazoxane in female patients with stage II breast cancer treated with anthracycline-based adjuvant chemotherapy
    Schnirer, I. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Dose and dose intensity effect of adjuvant anthracycline-based chemotherapy in early breast cancer -: A retrospective analysis
    Amador, ML
    Jimeno, A
    Hitt, R
    Cortés-Funes, H
    Colomer, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 269 - 273
12345